A $1.4m refund implies a total R&D spend of about 3.2M in that FY. Hmmm. Nicely subsidised by the taxpayer , might be worth scrutinising exactly what they’ve achieved in that FY for that large spend. No actual clinical work I believe. Lot of looking for stuff, talking about things, and “designing” things but it seems not much else based on their quarterly activity report I saw on the other thread . Looking at that activity report if you just changed one number- 1 replacing 2 in “sars cov 2” it might as well be a report from 2003.
Hmmmmm....
Beggars belief really there’s a SH base propping up this company and its CEO
A $1.4m refund implies a total R&D spend of about 3.2M in that...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |